BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jenner P, Rocha JF, Ferreira JJ, Rascol O, Soares-da-Silva P. Redefining the strategy for the use of COMT inhibitors in Parkinson's disease: the role of opicapone. Expert Rev Neurother 2021;21:1019-33. [PMID: 34525893 DOI: 10.1080/14737175.2021.1968298] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Xie L, Qi X, Wang X, He B, Wang Y, Zhang W, Yu Z, Deng M, Liang S, Lü M. Adverse event profiles of adjuvant treatment with opicapone in Parkinson’s disease: A systematic review and meta-analysis. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1042992] [Reference Citation Analysis]
2 Ferreira JJ, Poewe W, Rascol O, Stocchi F, Antonini A, Moreira J, Guimarães B, Rocha JF, Soares-da-Silva P. Effect of Opicapone on Levodopa Pharmacokinetics in Patients with Fluctuating Parkinson's Disease. Mov Disord 2022. [PMID: 36054562 DOI: 10.1002/mds.29193] [Reference Citation Analysis]
3 Salamon A, Zádori D, Szpisjak L, Klivényi P, Vécsei L. What is the impact of catechol-O-methyltransferase (COMT) on Parkinson's disease treatment? Expert Opin Pharmacother 2022;:1-6. [PMID: 35373688 DOI: 10.1080/14656566.2022.2060738] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Santos García D, Fernández Pajarín G, Oropesa-ruiz JM, Escamilla Sevilla F, Rahim López RRA, Muñoz Enríquez JG. Opicapone Improves Global Non-Motor Symptoms Burden in Parkinson’s Disease: An Open-Label Prospective Study. Brain Sciences 2022;12:383. [DOI: 10.3390/brainsci12030383] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Fabbri M, Ferreira JJ, Rascol O. COMT Inhibitors in the Management of Parkinson's Disease. CNS Drugs 2022. [PMID: 35217995 DOI: 10.1007/s40263-021-00888-9] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Jost WH, Buhmann C, Classen J, Eggert K, Kohl Z, Outeiro T, Tönges L, Woitalla D, Reichmann H. [Relevance of COMT inhibitors in the treatment of motor fluctuations]. Nervenarzt 2022. [PMID: 35044481 DOI: 10.1007/s00115-021-01237-3] [Reference Citation Analysis]